The Bionics Institute is proud to celebrate CEO Robert Klupacs, who has been recognised with an Individual Outstanding Achievement Award at the 2026 Impact Investment Awards.
This national recognition highlights Robert’s and Bionics Institute’s leadership in advancing medical technology research and our innovative approach to funding life-changing discoveries.
By bringing together philanthropy, impact investment and intellectual property licensing, Robert and Bionics Institute has helped accelerate the development of technologies that have the potential to improve lives on a global scale.
The awards were of the Impact Investment Summit held in Sydney on March 25/26.
\With over 850 attendees, the event connected investors with high-impact opportunities across sectors including healthcare, medtech and social innovation.
The Summit plays a key role in mobilising capital toward solutions that deliver measurable benefits for communities and patients, aligning closely with the Bionics Institute’s mission to translate research into real-world outcomes.
Under Robert’s leadership, the Institute continues to push the boundaries of what’s possible in hearing and neurological research—ensuring that breakthrough science can reach the people who need it most, faster.
Robert was recognised alongside an inspiring group of leaders, including Georgina Byron AM, CEO of the Snow Foundation; Hanna Ebeling CFA, CEO at SEFA; and Sally McCutchan OAM.
We also extend our congratulations to all organisations recognised at this year’s awards.
This recognition reflects not only individual achievement, but the growing importance of innovative funding models in bringing medical research to life—turning promising ideas into tangible health outcomes.
To learn more about the awards and the Impact Investment Summit, visit: https://impactinvestmentsummit.com/
